![Manuel Castellón Leal](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Manuel Castellón Leal
Private Equity Investor bei Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
Aktive Positionen von Manuel Castellón Leal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Private Equity Investor | 01.01.2001 | - |
Karriereverlauf von Manuel Castellón Leal
Ehemalige bekannte Positionen von Manuel Castellón Leal
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Direktor/Vorstandsmitglied | - | - |
Ausbildung von Manuel Castellón Leal
Universidad Complutense de Madrid | Undergraduate Degree |
Instituto de Empresa SL | Graduate Degree |
Statistik
International
Spanien | 5 |
Operativ
Private Equity Investor | 1 |
Director/Board Member | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cross Road Biotech Inversiones Biotecnológicas SGEIC SA
![]() Cross Road Biotech Inversiones Biotecnológicas SGEIC SA Investment ManagersFinance Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain. | Finance |
Traslational Cancer Drugs Pharma SL
![]() Traslational Cancer Drugs Pharma SL BiotechnologyHealth Technology Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain. | Health Technology |
- Börse
- Insiders
- Manuel Castellón Leal
- Erfahrung